Combined oral contraceptives reduce the risk of pregnancy primarily by inhibiting ovulation. This product combines drospirenone, an analogue of spironolactone that has both antimineralocorticoid and antiandrogenic effects with an estrogen plus folate supplementation. Levomefolate calcium 0.451 mg is included for reducing the risk of neural tube defects in case of accidental pregnancy.
Drospirenone/ethinylestradiol/levomefolic acid
Ethinylestradiol/drospirenone
Estradiol enantate/algestone acetophenide
Ethinylestradiol/norethisterone
Ethinylestradiol sulfonate/norethisterone acetate
Ethinylestradiol/cyproterone acetate
Conjugated estrogens/norgestrel
Ethinylestradiol/megestrol acetate